āĻšā§āĻŽNOTA âĸ FRA
add
āύā§āĻāĻžāϰāĻāĻŋāϏ
ā§§ā§§ā§Ļ.ā§Ļā§ĻâŦ
ā§§ā§Ŧ āĻ
āĻā§āĻā§, ā§Ž:ā§Ģā§Ģ:ā§§ā§Ŧ PM GMT +⧍ · EUR · FRA · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āϏā§āĻāĻDE-āĻ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤ āϏāĻŋāĻāĻŋāĻāϰāĻŋāĻāĻŋCH-āĻ āĻšā§āĻĄāĻā§ā§āĻžāϰā§āĻāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
⧧⧧⧍.ā§Ļā§ĻâŦ
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§§ā§Ļ⧝.ā§Ļā§ĻâŦ - ā§§ā§§ā§Ļ.ā§Ļā§ĻâŦ
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§Žā§Ž.⧍ā§ĻâŦ - ā§§ā§§ā§Ģ.ā§Ģā§ĻâŦ
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
⧍ā§ā§Ŧ.ā§¨ā§ŽāĻā§ USD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§Ŧā§Ļ.ā§Ļā§Ļ
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻāĻŦāϰ⧠āϰā§ā§āĻā§
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(USD) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§§ā§Ē.ā§Žā§ĒāĻļāĻ¤Â āĻā§ | ā§§ā§Ģ.⧍ā§Ŧ% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Ŧā§Ļā§Ģ.ā§Šā§Ļ āĻā§ | ā§Ģ.ā§¯ā§Š% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Ēā§Ļā§Ē.ā§§ā§Ļ āĻā§ | ⧍ā§Ē.ā§Ē⧝% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ⧍ā§.⧍ā§Ē | ā§Ž.ā§Ļā§§% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | ⧍.ā§Ē⧍ | ⧍⧍.ā§Žā§Ē% |
EBITDA | ā§Ŧā§Ģā§Ģ.ā§Ŧā§Ļ āĻā§ | ā§Šā§Ļ.ā§Ļā§Ž% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ā§§ā§§.⧧⧝% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(USD) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§Ŧā§ā§Š.⧍ā§Ļ āĻā§ | -⧍ā§Ļ.ā§§ā§Ģ% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§§ā§Ļā§Ē.ā§Ēā§ĻāĻā§ | ā§.ā§Ļā§% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§Ŧ⧍.ā§Šā§ĒāĻļāĻ¤Â āĻā§ | ⧧⧍.⧧⧍% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Ē⧍.ā§Ļā§ĢāĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§§ā§¯ā§Š.ā§Ģā§¯Â āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§Ģ.ā§§ā§Ŧ | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§§ā§Š.ā§Šā§% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§§ā§Ž.⧝⧍% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(USD) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Ēā§Ļā§Ē.ā§§ā§Ļ āĻā§ | ⧍ā§Ē.ā§Ē⧝% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ā§Ŧā§Ŧā§Ŧ.ā§Ēā§Ļ āĻā§ | ā§Šā§Ŧ.ā§ā§Ļ% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -⧍⧍ā§Ē.ā§Šā§Ļ āĻā§ | ā§Šā§Ļ.ā§Ļā§Ŧ% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Ģ⧍⧧.ā§Šā§Ļ āĻā§ | -ā§Ŧ⧍.⧝⧧% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | -ā§Ēā§§.ā§Ļā§Ļ āĻā§ | ā§ā§Š.ā§Žā§¨% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| ⧍ā§Ēā§Š.⧍ā§Ē āĻā§ | ā§Ģā§§.ā§¨ā§Ž% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
⧍⧝ āĻĢā§āĻŦ, ⧧⧝⧝ā§Ŧ
āϏāĻĻāϰ āĻĻāĻĒā§āϤāϰ
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§ā§Ģ,ā§Žā§Žā§Š